---
title: Loteprednol etabonate + Moxifloxacin
description: >-
  Loteprednol etabonate + Moxifloxacin is prescribed for the treatment of
  bacterial eye infections and inflammation, such as conjunctivitis (pink eye),
  and post-operative inflammation following ocular surgery.
is_banned: false
lastModified: '2025-09-22T17:22:09.516Z'
faqs:
  - q: >-
      What is the recommended dosage for Loteprednol etabonate + Moxifloxacin?**


      **A:** The typical dosage is 1-2 drops in the affected eye(s) four times
      daily. In the initial week, more frequent application might be necessary,
      potentially up to 1 drop every hour.
    a: >-
      A:** The typical dosage is 1-2 drops in the affected eye(s) four times
      daily. In the initial week, more frequent application might be necessary,
      potentially up to 1 drop every hour.
  - q: >-
      How long should this medication be used?**


      **A:** The duration of treatment depends on the specific condition and
      individual patient response. Post-operatively, it's generally used for two
      weeks. For infections, it's typically continued until the infection
      resolves.
    a: >-
      A:** The duration of treatment depends on the specific condition and
      individual patient response. Post-operatively, it's generally used for two
      weeks. For infections, it's typically continued until the infection
      resolves.
  - q: >-
      What are the common side effects patients should be aware of?**


      **A:**  Common side effects may include blurred vision, a burning or
      stinging sensation, eye discomfort, and mild redness.  Inform patients to
      report any severe or persistent side effects.
    a: >-
      A:**  Common side effects may include blurred vision, a burning or
      stinging sensation, eye discomfort, and mild redness.  Inform patients to
      report any severe or persistent side effects.
  - q: >-
      Can this medication be used in patients with glaucoma?**


      **A:** It should be used cautiously in patients with glaucoma, as it may
      increase intraocular pressure. Regular monitoring of intraocular pressure
      is essential.
    a: >-
      A:** It should be used cautiously in patients with glaucoma, as it may
      increase intraocular pressure. Regular monitoring of intraocular pressure
      is essential.
  - q: >-
      Is it safe to wear contact lenses while using this medication?**


      **A:**  Contact lens wear should generally be avoided during treatment
      with this medication.
    a: >-
      A:**  Contact lens wear should generally be avoided during treatment with
      this medication.
  - q: >-
      What should I do if a dose is missed?**


      **A:** Instill the missed dose as soon as it is remembered. Do not double
      the dose.
    a: >-
      A:** Instill the missed dose as soon as it is remembered. Do not double
      the dose.
  - q: >-
      Can this medication be used during pregnancy or breastfeeding?**


      **A:** Consult a physician for guidance regarding the safety of this
      medication during pregnancy and breastfeeding.
    a: >-
      A:** Consult a physician for guidance regarding the safety of this
      medication during pregnancy and breastfeeding.
  - q: >-
      Can I use over-the-counter eye drops with this medication?**


      **A:** Concomitant use of other ophthalmic medications should be avoided
      unless specifically directed by an ophthalmologist.
    a: >-
      A:** Concomitant use of other ophthalmic medications should be avoided
      unless specifically directed by an ophthalmologist.
  - q: >-
      What should I do if my symptoms worsen or don't improve?**


      **A:** Patients should be advised to contact their ophthalmologist if
      their symptoms worsen or don't improve within a few days.
    a: >-
      A:** Patients should be advised to contact their ophthalmologist if their
      symptoms worsen or don't improve within a few days.
---
## **Usage**

Loteprednol etabonate + Moxifloxacin is prescribed for the treatment of bacterial eye infections and inflammation, such as conjunctivitis (pink eye), and post-operative inflammation following ocular surgery.

**Pharmacological Classification:**

* Loteprednol etabonate: Corticosteroid, anti-inflammatory
* Moxifloxacin: Fluoroquinolone antibiotic

**Mechanism of Action:**

This combination medication works through two distinct mechanisms:

* **Loteprednol etabonate:**  Reduces inflammation by inhibiting the production of prostaglandins, chemical messengers that cause redness, swelling, and itching.
* **Moxifloxacin:**  Eradicates bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair.

## **Alternate Names**

There is no internationally recognized non-proprietary name for this combination product. It is often referred to as Loteprednol/Moxifloxacin.

**Brand Names:**  Several brand names exist including Zeximox-LP, Moxigram LX, and StayHappi, among others. Regional variations in brand names are common.

## **How It Works**

**Pharmacodynamics:**

* **Loteprednol etabonate:**  Exerts its anti-inflammatory effect by binding to glucocorticoid receptors, suppressing the migration of neutrophils and decreasing capillary permeability in the eye.
* **Moxifloxacin:**  Exerts bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, ultimately leading to bacterial cell death.

**Pharmacokinetics:**

* **Loteprednol etabonate:** Primarily metabolized in the liver and eliminated through hepatic excretion. Minimal systemic absorption occurs after topical ocular administration.
* **Moxifloxacin:**  Following topical ocular administration, a small amount of moxifloxacin is absorbed systemically.  It is metabolized in the liver via glucuronidation and sulfonation, with subsequent renal and fecal elimination.

**Mode of Action (Cellular/Molecular):**  As described above, loteprednol etabonate acts on intracellular glucocorticoid receptors, influencing gene expression and downstream anti-inflammatory pathways. Moxifloxacin interferes with bacterial DNA replication by targeting DNA gyrase and topoisomerase IV.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

Instill one to two drops into the affected eye(s) four times daily.  During the initial week of treatment, more frequent administration (up to one drop hourly) may be necessary.  Treatment typically begins 24 hours after surgery and continues for two weeks in post-operative settings.

#### **Children:**

Dosage and usage in children should be determined by a physician based on the specific condition being treated and the individual patient's needs.


#### **Special Cases:**

* **Elderly Patients:** No specific dosage adjustments are typically required. Monitor for potential systemic absorption and side effects.
* **Patients with Renal Impairment:** Caution is advised; monitor renal function.
* **Patients with Hepatic Dysfunction:** Close monitoring is recommended.
* **Patients with Comorbid Conditions:**  Individualized dosing may be necessary. Consult a specialist for conditions like glaucoma or diabetes.

### **Clinical Use Cases**

The primary clinical use cases are bacterial conjunctivitis and post-operative inflammation. Dosages for other settings are not generally recommended.


### **Dosage Adjustments:**

Dose adjustments should be determined by the treating ophthalmologist based on the patient's individual response and clinical condition.

## **Side Effects**

### **Common Side Effects:**

* Blurred vision
* Burning or stinging sensation
* Eye discomfort
* Redness of the eyes
* Foreign body sensation
* Headache
* Photophobia
* Tearing

### **Rare but Serious Side Effects:**

* Allergic reactions (e.g., rash, itching, swelling)
* Corneal thinning or ulceration
* Increased intraocular pressure
* Vision changes

### **Long-Term Effects:**

Prolonged use of corticosteroids like loteprednol can lead to glaucoma, cataracts, and increased susceptibility to secondary ocular infections.

### **Adverse Drug Reactions (ADR):**

Any signs of hypersensitivity, significant increase in intraocular pressure, or corneal changes should prompt immediate discontinuation and consultation with an ophthalmologist.



## **Contraindications**

* Hypersensitivity to loteprednol etabonate, moxifloxacin, or any component of the formulation
* Viral or fungal infections of the eye
* Mycobacterial infections of the eye
* Uncontrolled glaucoma


## **Drug Interactions**

No clinically significant drug interactions are typically expected with topical ocular administration.

## **Pregnancy and Breastfeeding**

The safety of this combination medication during pregnancy and breastfeeding has not been fully established. Consult a physician before use.

## **Drug Profile Summary**

* **Mechanism of Action:** Loteprednol reduces inflammation; Moxifloxacin inhibits bacterial DNA replication.
* **Side Effects:** Blurred vision, burning/stinging, eye discomfort, redness, headache, photophobia.
* **Contraindications:** Hypersensitivity, viral/fungal/mycobacterial eye infections, uncontrolled glaucoma.
* **Drug Interactions:**  No significant interactions are usually expected with topical administration.
* **Pregnancy & Breastfeeding:** Consult a physician.
* **Dosage:** 1-2 drops four times daily; individual adjustments may be necessary.
* **Monitoring Parameters:** Intraocular pressure, corneal integrity, signs of infection.

## **Popular Combinations**

Loteprednol/Moxifloxacin is itself a popular combination. Combining it with other ophthalmic medications is generally not recommended without specialist consultation.

## **Precautions**

* **General Precautions:** Thorough eye examination prior to use.
* **Specific Populations:**  Consult a physician regarding use in pregnancy/breastfeeding, children, and the elderly.
* **Lifestyle Considerations:**  Temporary blurred vision may affect driving.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Loteprednol etabonate + Moxifloxacin?**

**A:** The typical dosage is 1-2 drops in the affected eye(s) four times daily. In the initial week, more frequent application might be necessary, potentially up to 1 drop every hour.

### **Q2: How long should this medication be used?**

**A:** The duration of treatment depends on the specific condition and individual patient response. Post-operatively, it's generally used for two weeks. For infections, it's typically continued until the infection resolves.

### **Q3: What are the common side effects patients should be aware of?**

**A:**  Common side effects may include blurred vision, a burning or stinging sensation, eye discomfort, and mild redness.  Inform patients to report any severe or persistent side effects.


### **Q4: Can this medication be used in patients with glaucoma?**

**A:** It should be used cautiously in patients with glaucoma, as it may increase intraocular pressure. Regular monitoring of intraocular pressure is essential.


### **Q5: Is it safe to wear contact lenses while using this medication?**

**A:**  Contact lens wear should generally be avoided during treatment with this medication.

### **Q6: What should I do if a dose is missed?**

**A:** Instill the missed dose as soon as it is remembered. Do not double the dose.

### **Q7: Can this medication be used during pregnancy or breastfeeding?**

**A:** Consult a physician for guidance regarding the safety of this medication during pregnancy and breastfeeding.


### **Q8:  Can I use over-the-counter eye drops with this medication?**

**A:** Concomitant use of other ophthalmic medications should be avoided unless specifically directed by an ophthalmologist.

### **Q9: What should I do if my symptoms worsen or don't improve?**

**A:** Patients should be advised to contact their ophthalmologist if their symptoms worsen or don't improve within a few days.




